<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 30 Jan 2021 12:04:38 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>国采省下超千亿，三甲医院获百万奖励！1类新药低价挂网，137个药品“退市”</title><link>https://mp.weixin.qq.com/s/6uy-wL4Z9_Tjg5iNwCoz8w</link><description></description><content:encoded><![CDATA[国采省下超千亿，三甲医院获百万奖励！1类新药低价挂网，137个药品“退市”]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:59:36 +0800</pubDate></item><item><title>集采冲击！150亿市场扬子江、正大天晴、司太立抢先过评，造影剂龙头恒瑞急了？</title><link>https://mp.weixin.qq.com/s/GPXNwUg8Wx56HJa7OtyK4w</link><description></description><content:encoded><![CDATA[集采冲击！150亿市场扬子江、正大天晴、司太立抢先过评，造影剂龙头恒瑞急了？]]></content:encoded><pubDate>Fri, 29 Jan 2021 16:06:38 +0800</pubDate></item><item><title>【重磅】齐鲁发威！拿下复方降糖药首仿</title><link>https://mp.weixin.qq.com/s/Tw2hESUGm1mc8376jPuRnA</link><description></description><content:encoded><![CDATA[【重磅】齐鲁发威！拿下复方降糖药首仿]]></content:encoded><pubDate>Fri, 29 Jan 2021 16:06:38 +0800</pubDate></item><item><title>【瞩目】科伦再添首仿！10款肠外营养药霸屏</title><link>https://mp.weixin.qq.com/s/B-F55dC-RE8NZdfeWMrDzA</link><description></description><content:encoded><![CDATA[【瞩目】科伦再添首仿！10款肠外营养药霸屏]]></content:encoded><pubDate>Fri, 29 Jan 2021 16:06:38 +0800</pubDate></item><item><title>【市场】海思科将拿下$28亿大品种</title><link>https://mp.weixin.qq.com/s/aeLaxrH_wco2k_zEbdN-bg</link><description></description><content:encoded><![CDATA[【市场】海思科将拿下$28亿大品种]]></content:encoded><pubDate>Fri, 29 Jan 2021 16:06:38 +0800</pubDate></item><item><title>“中药一哥”地位生变？肝炎药王独霸市场销售再暴涨，逼“国民神药”出大招</title><link>https://mp.weixin.qq.com/s/s_iN7VDR2qTco9Bqkv-unw</link><description></description><content:encoded><![CDATA[“中药一哥”地位生变？肝炎药王独霸市场销售再暴涨，逼“国民神药”出大招]]></content:encoded><pubDate>Thu, 28 Jan 2021 15:21:07 +0800</pubDate></item><item><title>【重磅】科伦首个吸入剂来了！200亿市场急速升温</title><link>https://mp.weixin.qq.com/s/GqupCk6eWX-_SQxz_4kDMg</link><description></description><content:encoded><![CDATA[【重磅】科伦首个吸入剂来了！200亿市场急速升温]]></content:encoded><pubDate>Thu, 28 Jan 2021 15:21:07 +0800</pubDate></item><item><title>【瞩目】TOP3止血药注射剂大卖，倍特要冲击首家过评</title><link>https://mp.weixin.qq.com/s/7YZt-9Io2hXMHLvJ8LN92w</link><description></description><content:encoded><![CDATA[【瞩目】TOP3止血药注射剂大卖，倍特要冲击首家过评]]></content:encoded><pubDate>Thu, 28 Jan 2021 15:21:07 +0800</pubDate></item><item><title>【焦点】扬子江、复星、天晴……13个产品压线过评，4个竞争超激烈</title><link>https://mp.weixin.qq.com/s/ZIZwDiDfnXwTqe_OUii9LQ</link><description></description><content:encoded><![CDATA[【焦点】扬子江、复星、天晴……13个产品压线过评，4个竞争超激烈]]></content:encoded><pubDate>Thu, 28 Jan 2021 15:21:07 +0800</pubDate></item><item><title>142家药企晒2020成绩单！九州通、长春高新……净利润超30亿，41家翻倍，这5家续亏</title><link>https://mp.weixin.qq.com/s/Bv9xF6N-s0JA3fcjtYzIlA</link><description></description><content:encoded><![CDATA[142家药企晒2020成绩单！九州通、长春高新……净利润超30亿，41家翻倍，这5家续亏]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>【瞩目】30亿注射剂大品种！海思科过评了，石药、豪森等蜂拥而至</title><link>https://mp.weixin.qq.com/s/Fq1IspheT0ij3RnqR7tOiw</link><description></description><content:encoded><![CDATA[【瞩目】30亿注射剂大品种！海思科过评了，石药、豪森等蜂拥而至]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>【关注】北京药企抢首仿！阿斯利康4亿口服降糖药受冲击</title><link>https://mp.weixin.qq.com/s/Yd1DE0UXsjYLjcITKc21Uw</link><description></description><content:encoded><![CDATA[【关注】北京药企抢首仿！阿斯利康4亿口服降糖药受冲击]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>【获批】6亿心血管药“激战”！3家药企同日过评</title><link>https://mp.weixin.qq.com/s/InPtoRQzDDPny1TEe-NgcA</link><description></description><content:encoded><![CDATA[【获批】6亿心血管药“激战”！3家药企同日过评]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:56:18 +0800</pubDate></item><item><title>科伦开挂了！拿下15个重磅品种，36个过评品种亮眼，11款1类新药、41个新品在路上</title><link>https://mp.weixin.qq.com/s/_QEs4TI8L7AGbRq4y2HSqw</link><description></description><content:encoded><![CDATA[科伦开挂了！拿下15个重磅品种，36个过评品种亮眼，11款1类新药、41个新品在路上]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>【瞩目】东阳光药将拿下$120亿明星抗凝药</title><link>https://mp.weixin.qq.com/s/l73K5G8PZBlp-x_Sjbb2OA</link><description></description><content:encoded><![CDATA[【瞩目】东阳光药将拿下$120亿明星抗凝药]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>【市场】常用抗痛风药！首家过评企业来了</title><link>https://mp.weixin.qq.com/s/BX579RQkq9Prrdni8IqdSw</link><description></description><content:encoded><![CDATA[【市场】常用抗痛风药！首家过评企业来了]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>【干货】石药集团支招！缩短研发周期，降低研发成本</title><link>https://mp.weixin.qq.com/s/XENx7eLWrkpSWzdWgTGBOA</link><description></description><content:encoded><![CDATA[【干货】石药集团支招！缩短研发周期，降低研发成本]]></content:encoded><pubDate>Tue, 26 Jan 2021 16:05:31 +0800</pubDate></item><item><title>“一哥”易主，药店TOP20洗牌！3大品种大涨，慢病药“霸屏”，正大天晴“崛起”</title><link>https://mp.weixin.qq.com/s/k5zKNluLlq-qAoMM1CoasA</link><description></description><content:encoded><![CDATA[“一哥”易主，药店TOP20洗牌！3大品种大涨，慢病药“霸屏”，正大天晴“崛起”]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:03:55 +0800</pubDate></item><item><title>【重磅】超35亿大品种扬子江批了，龙头地位稳如泰山</title><link>https://mp.weixin.qq.com/s/lvC1JhtRYP13xLZqvXbN7A</link><description></description><content:encoded><![CDATA[【重磅】超35亿大品种扬子江批了，龙头地位稳如泰山]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:03:55 +0800</pubDate></item><item><title>【瞩目】奥赛康发力，重磅注射剂首家过评</title><link>https://mp.weixin.qq.com/s/Gk9rvt4mzKWbwWQw0y_J2A</link><description></description><content:encoded><![CDATA[【瞩目】奥赛康发力，重磅注射剂首家过评]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:03:55 +0800</pubDate></item></channel></rss>